Related Experiment Videos
Anaplastic thyroid carcinoma associated with Graves' disease
Takafumi Majima1, Yasato Komatsu, Kentaro Doi
1Department of Endocrinology and Metabolism, Rakuwakai Otowa Hospital, Kyoto, Japan.
Endocrine Journal
|November 15, 2005
Summary
This case report details a rare instance of coexisting anaplastic thyroid carcinoma and Graves' disease. It highlights the critical need for vigilant evaluation of thyroid nodules in patients with Graves' disease to ensure early cancer detection.
Area of Science:
- Endocrinology
- Oncology
- Pathophysiology
Background:
- Graves' disease (GD) is an autoimmune disorder causing hyperthyroidism.
- Anaplastic thyroid carcinoma (ATC) is an aggressive form of thyroid cancer.
- Coexistence of GD and thyroid malignancy presents diagnostic and management challenges.
Observation:
- A 79-year-old woman with GD presented with a palpable neck mass.
- Thyroid function tests indicated hyperthyroidism with elevated thyroid-stimulating antibodies.
- Ultrasonography revealed a suspicious nodule, and fine needle aspiration biopsy was inconclusive, leading to open biopsy confirming ATC.
Findings:
- The patient had coexisting Graves' disease and anaplastic thyroid carcinoma.
- Thyroid-stimulating antibodies in GD may potentially stimulate malignant transformation.
- The anaplastic thyroid carcinoma had metastasized regionally and to the lungs.
Implications:
- This case underscores the importance of thorough evaluation of thyroid nodules in patients with GD.
- Early detection of malignancy in GD patients is crucial due to increased risk.
- Understanding the interplay between autoimmune thyroid disease and cancer development is vital.